Depolarizing NMJ blockers (depolarizing muscle relaxants)


Fast onset, short duration

Agents

  • Succinylcholine (suxamethonium)

Indications

  • Anesthesia induction (esp. rapid sequence induction)

Monitoring

  • Train-of-four stimulation shows an equal decrease in the amplitude of all 4 muscle twitches.
    • The muscle fiber becomes unresponsive to any further stimulation

Adverse effects

  • Hyperkalemia
    • Mechanism: depolarization of large muscle groups → efflux of potassium ions into the extracellular space
    • Succinylcholine is contraindicated in case of hyperkalemia or in conditions associated with a high-risk of hyperkalemia, including:
  • Prolonged muscle paralysis, respiratory depression and/or apnea in patients with a congenital deficiency of plasma cholinesterase
    • AChE (“True Cholinesterase”):
      • Function: Rapidly hydrolyzes acetylcholine (ACh) in synaptic clefts & neuromuscular junctions (NMJs) to terminate neurotransmission. Essential for precise control of nerve impulses.
      • Location: Primarily at postsynaptic NMJs, cholinergic synapses in CNS, red blood cells.
    • PChE (Butyrylcholinesterase, “Plasma/Serum Cholinesterase”):
      • Function: Hydrolyzes exogenous choline esters (e.g., succinylcholine, mivacurium) and some local anesthetics (e.g., procaine, cocaine). Physiological role not fully understood, but may be involved in nerve signal transmission.
      • Location: Synthesized in the liver; found in plasma, liver, pancreas, heart, brain (white matter).
      • Atypical pseudocholinesterase
        • Pseudocholinesterase is responsible for the breakdown of succinylcholine through ester hydrolysis.
        • Atypical pseudocholinesterase breaks down succinylcholine slowly and thus prolongs the duration of muscle relaxation during anesthesia from a few minutes to a few hours; this may cause respiratory depression.
  • Malignant hyperthermia

Nondepolarizing NMJ blockers (nondepolarizing muscle relaxants)


Slow onset, long duration

Mechanism of action

  • Compete with ACh to bind with the (nicotinic) ACh receptors at the motor end plate (competitive antagonists) → prevention of motor end plate depolarization (nondepolarization block)

Agents

  • Rocuronium
  • Vecuronium
  • Atracurium

Indications

  • Rapid-sequence induction of anesthesia when succinylcholine is contraindicated

Monitoring

  • Train-of-four stimulation shows a fade-off in the amplitude of the muscle twitch
    • NDMRs block nicotinic acetylcholine receptors (nAChRs) not only at the postsynaptic membrane but also at presynaptic nerve terminals
    • These presynaptic receptors normally provide positive feedback for additional ACh release
    • When blocked, there’s reduced mobilization of ACh vesicles for subsequent stimuli